Federal Register / Vol. 62, No. 165 / Tuesday, August 26, 1997 / Notices 45273

moving all bulk manufacturing of

methylphenidate to the above location.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the proposed registration.

Any such comments, or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, D.C. 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than (60 days

from publication).

Dated: July 29, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–22564 Filed 8–25–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances;

Notice of Registration

By Notice dated April 24, 1997, and

published in the Federal Register on

May 21, 1997 (62 FR 27770), Research

Biochemicals, Inc., Limited Partnership,

Attn: Richard Milius, 1–3 Strathmore

Road, Natick, Massachusetts 01760,

made application to the Drug

Enforcement Administration to be

registered as an importer of the basic

classes of controlled substances listed

below:

Drug Schedule

Methaqualone (2565) ................... I

Ibogaine (7260) ............................ I

Tetrahydrocannabinols (7370) ...... I

Bufotenine (7433) ......................... I

Dimethyltryptamine (7435) ........... I

Etorphine (except Hcl) (9056) ...... I

Methylphenidate (1724) ................ II

Pentobarbital (2270) ..................... II

Diprenorphine (9058) .................... II

Etorphine Hydrochloride (9059) ... II

Diphenoxylate (9170) ................... II

Metazocine (9240) ........................ II

Methadone (9250) ........................ II

Fentanyl (9801) ............................ II

No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

Section 823(a) and determined that the

registration of Research Biochemicals to

import the listed controlled substances

is consistent with the public interest

and with United States obligations

under international treaties,

conventions, or protocols in effect on

May 1, 1971, at this time. Therefore,

pursuant to Section 1008(a) of the

Controlled Substances Import and

Export Act and in accordance with Title

21, Code of Federal Regulations, Section

1301.34, the above firm is granted

registration as an importer of the basic

classes of controlled substances listed

above.

Dated: July 21, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–22565 Filed 8–25–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated April 24, 1997, and

published in the Federal Register on

May 21, 1997, (62 FR 27776), Research

Biochemicals, Limited Partnership, One

Strathmore Road, Natick, Massachusetts

01760, made application to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

the basic classes of controlled

substances listed below:

Drug Schedule

Cathinone (1235) .......................... I

Methcathinone (1237) ................... I

Alpha-Ethyltryptamine (7249) ....... I

Lysergic acid diethylamide (7315) I

2,5-Dimethoxyamphetamine

(7396).

I

3,4-Methylenedioxymethamphetamine (7405). Dimethyltryptamine (7435).I

1-[1-(2-

Thienyl)cyclohexyl]piperidine

(7470).

I

Heroin (9200) ................................ I

Normorphine (9313) ..................... I

Phencyclidine (7471) .................... II

Benzoylecgonine (9180) ............... II

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Research Biochemicals to

manufacture the listed controlled

substances is consistent with the public

interest at this time. Therefore, pursuant

to 21 U.S.C. § 823 and 28 C.F.R. §§ 0.100

and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: July 29, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–22566 Filed 8–25–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated April 15, 1997, and

published in the Federal Register on

May 12, 1997, (62 FR 25972), Research

Triangle Institute, Kenneth H. Davis, Jr.,

Hermann Building, East Institute Drive,

P.O. Box 12194, Research Triangle Park,

North Carolina 27709, made application

by renewal to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Marihuana (7360) ......................... I

Cocaine (9041) ............................. II

DEA has considered the factors in

Title 21, United States Code, Section

823(a), as well as information provided

by other bulk manufacturers, and

determined that the registration of

Research Triangle Institute to

manufacture the listed controlled

substances is consistent with the public

interest at this time. Therefore, pursuant

to 21 U.S.C. § 823 and 28 C.F.R. §§ 0.100

and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: July 29, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–22568 Filed 8–25–97; 8:45 am]

BILLING CODE 4410–09–M